The Benefit of Combining Docetaxel with Androgen Deprivation Therapy in Localized and Metastatic Hormone-sensitive Prostate Cancer is Predicted by ERG Expression: An Analysis of Two GETUG Phase 3 Trials
Saved in:
Published in | European urology oncology |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier
01.07.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
ISSN: | 2588-9311 2588-9311 |
---|---|
DOI: | 10.1177/2472630317740831 |